Your browser doesn't support javascript.
loading
Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein.
Alshareeda, Alaa Tarig; Negm, Ola H; Aleskandarany, Mohammed A; Green, Andrew R; Nolan, Christopher; TigHhe, Patrick J; Madhusudan, Srinivasan; Ellis, Ian O; Rakha, Emad A.
Afiliação
  • Alshareeda AT; Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK.
  • Negm OH; King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.
  • Aleskandarany MA; Immunology, School of Life Sciences, University of Nottingham, Nottingham, UK.
  • Green AR; Medical Microbiology and Immunology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
  • Nolan C; Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK.
  • TigHhe PJ; Pathology Department, Menofia Faculty of Medicine, Menoufia, Egypt.
  • Madhusudan S; Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK.
  • Ellis IO; Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK.
  • Rakha EA; Immunology, School of Life Sciences, University of Nottingham, Nottingham, UK.
Breast Cancer Res Treat ; 159(1): 41-53, 2016 08.
Article em En | MEDLINE | ID: mdl-27464795

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Núcleo Celular / Citoplasma / Rad51 Recombinase Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Núcleo Celular / Citoplasma / Rad51 Recombinase Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido